Stephens Reaffirms “Equal Weight” Rating for Molina Healthcare (NYSE:MOH)

Stephens reaffirmed their equal weight rating on shares of Molina Healthcare (NYSE:MOH) in a research note released on Thursday, Benzinga reports. They currently have a $390.00 price target on the stock.

A number of other equities research analysts have also issued reports on MOH. StockNews.com lowered shares of Molina Healthcare from a strong-buy rating to a buy rating in a report on Thursday, February 8th. Cantor Fitzgerald restated an overweight rating and set a $406.00 target price on shares of Molina Healthcare in a report on Thursday, April 4th. Truist Financial lifted their price objective on Molina Healthcare from $435.00 to $460.00 and gave the stock a buy rating in a research report on Tuesday, February 20th. Barclays began coverage on Molina Healthcare in a research note on Wednesday, March 6th. They issued an equal weight rating and a $437.00 target price for the company. Finally, Bank of America lowered shares of Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price objective for the company. in a report on Thursday, March 28th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of Hold and an average price target of $400.70.

Molina Healthcare Stock Performance

Shares of NYSE MOH opened at $342.23 on Thursday. The stock has a market cap of $20.05 billion, a price-to-earnings ratio of 18.57, a PEG ratio of 0.96 and a beta of 0.47. Molina Healthcare has a 12 month low of $266.35 and a 12 month high of $423.92. The company has a 50 day simple moving average of $390.34 and a two-hundred day simple moving average of $372.35. The company has a current ratio of 1.49, a quick ratio of 1.54 and a debt-to-equity ratio of 0.53.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, topping the consensus estimate of $5.46 by $0.27. The firm had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. Molina Healthcare’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same period last year, the company earned $5.81 earnings per share. As a group, analysts predict that Molina Healthcare will post 23.62 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $384.06, for a total value of $273,066.66. Following the sale, the director now directly owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Richard M. Schapiro sold 711 shares of Molina Healthcare stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the transaction, the director now directly owns 12,207 shares of the company’s stock, valued at $4,688,220.42. The disclosure for this sale can be found here. Insiders sold a total of 16,711 shares of company stock valued at $6,472,517 over the last 90 days. 1.10% of the stock is owned by company insiders.

Institutional Trading of Molina Healthcare

Hedge funds have recently made changes to their positions in the business. CWM LLC lifted its holdings in Molina Healthcare by 8.7% during the 3rd quarter. CWM LLC now owns 1,395 shares of the company’s stock worth $457,000 after buying an additional 112 shares in the last quarter. AE Wealth Management LLC boosted its holdings in Molina Healthcare by 33.5% in the third quarter. AE Wealth Management LLC now owns 1,159 shares of the company’s stock valued at $380,000 after purchasing an additional 291 shares during the period. Czech National Bank grew its stake in Molina Healthcare by 47.6% during the 3rd quarter. Czech National Bank now owns 10,189 shares of the company’s stock worth $3,341,000 after purchasing an additional 3,288 shares in the last quarter. Ballentine Partners LLC increased its holdings in Molina Healthcare by 1.4% during the 3rd quarter. Ballentine Partners LLC now owns 2,940 shares of the company’s stock worth $964,000 after purchasing an additional 41 shares during the period. Finally, Commonwealth Equity Services LLC raised its position in Molina Healthcare by 1.1% in the 3rd quarter. Commonwealth Equity Services LLC now owns 17,879 shares of the company’s stock valued at $5,862,000 after purchasing an additional 192 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.